Recro Pharma (REPH) News Today → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free REPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFuji Pharma Co. Ltd.wsj.com - January 30 at 3:34 PMHere's what Wall Street expects from Recro Pharma's earnings reportmarkets.businessinsider.com - November 7 at 12:00 PMUS supreme court halts Purdue Pharma deal that shields Sacklers from lawsuitstheguardian.com - August 16 at 1:59 AMWhat Wall Street expects from Recro Pharma's earningsmarkets.businessinsider.com - August 9 at 7:25 AMMankind Pharma Ltd (MNKI)investing.com - August 3 at 9:00 AMBaudax Bio acquires Maryland biotechnology firm TeraImmune; stock jumpsbizjournals.com - June 30 at 12:44 PMPomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Recro Pharma, Inc. Common Stock – SCTLbenzinga.com - June 24 at 9:08 AMSocietal CDMO Increuters.com - April 20 at 9:24 AMRecro Pharma, Inc.: Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformationfinanznachrichten.de - March 22 at 10:51 PMIs Recro Pharma (REPH) a Worthy Investment?finance.yahoo.com - March 22 at 8:32 AMRecro Pharma (NASDAQ:REPH) Coverage Initiated by Analysts at StockNews.commarketbeat.com - March 18 at 4:23 AMRecro Pharma (NASDAQ:REPH) Coverage Initiated by Analysts at StockNews.commarketbeat.com - March 2 at 1:51 AMRecap: Recro Pharma Q4 Earningsbenzinga.com - March 1 at 11:55 PMRecro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facilityfinance.yahoo.com - February 23 at 11:18 AMRecro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022finance.yahoo.com - February 22 at 8:15 PMRecro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Preventionfinance.yahoo.com - January 26 at 8:52 AMRecro Pharma (NASDAQ:REPH) Downgraded by Zacks Investment Researchmarketbeat.com - January 6 at 8:52 AMRecro to Present at H.C. Wainwright BioConnect 2022 Conferencefinance.yahoo.com - January 3 at 7:55 AMDo Options Traders Know Something About Recro Pharma (REPH) Stock We Don't?finance.yahoo.com - December 8 at 2:55 PMRecro Pharma (NASDAQ:REPH) Cut to "Hold" at Zacks Investment Researchmarketbeat.com - December 8 at 6:29 AMRecro to Report Financial Results for Third Quarter 2021 on November 9, 2021finance.yahoo.com - November 2 at 6:54 PMRecro Enters Into Master Commercial Supply and Services Agreement With Otsukafinance.yahoo.com - October 27 at 7:58 AMRecro Pharma Signs Renewable Energy Agreement with Georgia Powermarketwatch.com - September 21 at 9:24 AMRecro Signs Renewable Energy Agreement With Georgia Powerfinance.yahoo.com - September 21 at 9:24 AMRecro Pharma (REPH) Moves to Buy: Rationale Behind the Upgradefinance.yahoo.com - September 16 at 3:05 PMRecro Pharma goes bicoastal with 'transformative' acquisition of San Diego firm for $50Mbizjournals.com - August 16 at 3:39 PMRecro Pharma Buys San Diego-Based Irisys for $50 Million >REPHmarketwatch.com - August 13 at 3:51 PMRecro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMOfinance.yahoo.com - August 13 at 10:51 AMRecro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMOfinance.yahoo.com - August 10 at 8:02 AMRecro Pharma is about to announce its earnings — here's what to expectmarkets.businessinsider.com - August 7 at 2:24 PMRecro Pharma Inc hosts conference call for investorsmarkets.businessinsider.com - August 6 at 5:30 PMRecro To Report Financial Results for Second Quarter 2021 on August 9, 2021finance.yahoo.com - August 2 at 5:21 PM Get Recro Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> REPH Media Mentions By Week REPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REPH News Sentiment▼0.000.44▲Average Medical News Sentiment REPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REPH Articles This Week▼00▲REPH Articles Average Week Get Recro Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Coya Therapeutics News Citius Pharmaceuticals News Societal CDMO News Immunic News Adagene News OptiNose News Repare Therapeutics News Nuvectis Pharma News Annovis Bio News CytomX Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recro Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
